metastatic pancreatic cancer

Ipsen reports positive data from pancreatic ductal adenocarcinoma trial
Clinical Trials Arena
Mon, 01/23/23 - 10:53 am
Ipsen
Onivyde
metastatic pancreatic cancer
pancreatic cancer
clinical trials
Addition of Pegilodecakin to FOLFOX Did Not Improve OS in Metastatic Pancreatic Cancer
Cancer Therapy Advisor
Fri, 01/24/20 - 12:05 am
Eli Lilly
pegilodecakin
pancreatic cancer
clinical trials
metastatic pancreatic cancer
Futility analysis augurs defeat in pivotal trial testing of NuCana's lead drug in metastatic pancreatic cancer
Endpoints
Wed, 08/21/19 - 09:51 am
Nucana
clinical trials
Acelarin
metastatic pancreatic cancer
AbbVie's Imbruvica misses pancreatic cancer endpoints
BioCentury
Fri, 01/18/19 - 09:16 pm
AbbVie
Imbruvica
clinical trials
PCYC-1137
metastatic pancreatic cancer
NewLink inks deal with AstraZeneca to test Imfinzi combo
BioPharma Dive
Thu, 09/28/17 - 09:57 am
NewLink Genetics
AstraZeneca
Imfinzi
indoximod
metastatic pancreatic cancer
U.S. FDA Grants Priority Review for MM-398 New Drug Application
Yahoo
Thu, 06/25/15 - 08:59 am
FDA
MM-398
Merrimack Pharmaceuticals
metastatic pancreatic cancer
Halozyme Phase 2 Clinical Study Of Investigational Drug PEGPH20 Shows Doubling Of Progression-free Survival And Improvement Trend In Overall Survival In High HA Metastatic Pancreatic Cancer Patients
Yahoo
Sun, 05/31/15 - 11:57 am
Halozyme
PEGPH20
ASCO
metastatic pancreatic cancer
Merrimack Pharmaceuticals and Baxter BioScience Announce Completion of New Drug Application Submission to U.S. FDA for MM-398 as a Treatment for Post-Gemcitabine Metastatic Pancreatic Cancer
Yahoo
Mon, 04/27/15 - 09:44 am
Merrimack Pharmaceuticals
Baxter International
MM-398
metastatic pancreatic cancer
Halozyme's PEGPH20 Study S1313 Clinical Hold Lifted by FDA
Yahoo/Zacks
Sat, 09/20/14 - 08:52 am
Halozyme
PEGPH20
pancreatic cancer
metastatic pancreatic cancer
Halozyme's PEGPH20 Program Gains Fast Track Designation
Yahoo/Zacks
Sat, 09/6/14 - 09:18 am
Halozyme
PEGPH20
metastatic pancreatic cancer
pancreatic cancer
Merrimack Pharmaceuticals: Setting The Record Straight On MM 398
Seeking Alpha
Fri, 05/16/14 - 03:46 pm
Merrimack Pharmaceuticals
MM-398
metastatic pancreatic cancer
Merrimack cancer drug combination improves survival in study
Yahoo/Reuters
Thu, 05/1/14 - 08:27 am
Merrimack Pharmaceuticals
metastatic pancreatic cancer
MM-398
OncoGenex's Apatorsen in Phase II Study
Yahoo/Zacks
Thu, 08/29/13 - 09:40 am
OncoGenex
apatorsen
metastatic pancreatic cancer
Gemzar
Celgene
Abraxane
OGX-427